Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Patient Age and Donor HLA Matching Can Stratify Allogeneic Hematopoietic Cell Transplantation (HCT) Patients into Prognostic Groups: A Collaborative Study

Sunu Cyriac, MD MBBS, Auro Viswabandya, MD, Zeyad Al-Shaibani, MD, Jeffrey H. Lipton, MD PhD, Rajat Kumar, MD, Wilson Lam, MD, Dennis Dong Hwan Kim, MD, Arjun Law, MDDM, Tobias Gedde-Dahl, MD PhD, Yngvar Floisand, MD PhD, Mats Remberger, PhD, Jonas Mattsson, MD, Fotios V. Michelis, MD PhD

Blood (2019) 134 (Supplement_1): 3341.

https://doi.org/10.1182/blood-2019-125941

Published: 2019

Journal Articles

Risk Factors for Primary and Secondary Graft Failure in Allogenic Hematopoietic Cell Transplantation: A Single Center Study

Zeyad Al-Shaibani, MD, Eshrak AL-Shaibani, MD, Mats Remberger, PhD, Wilson Lam, MD, Arjun Law, MD, Fotios V. Michelis, MD PhD, Auro Viswabandya, MD, Dennis Dong Hwan Kim, MD, Jeffrey H. Lipton, MD PhD, Jonas Mattson, MD PhD, Rajat Kumar, MD

Blood (2019) 134 (Supplement_1): 2046.

https://doi.org/10.1182/blood-2019-124208

Published: 2019

Journal Articles

Risks and Benefits of Sex-Mismatched Hematopoietic Cell Transplantation Differ By Conditioning Intensity

Hideki Nakasone, Mats Remberger, PhD, Lu Tian, PhD, Petter Brodin, MD PhD, Bita Sahaf, Fang Wu, Robert Lowsky, MD, Jonas Mattsson, MD PhD, Robert S. Negrin, MD, David B. Miklos, Everett Meyer, MD PhD

Blood (2014) 124 (21): 2537.

https://doi.org/10.1182/blood.V124.21.2537.2537

Published: 2014

Journal Articles

Graft Failure In Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation

Richard Olsson, MD, PhD, Daniel Moreno Berggren, MD, Olle Ringden, MD, PhD, Jonas Mattsson, MD, PhD, Mats Remberger, PhD

Blood (2013) 122 (21): 4559.

https://doi.org/10.1182/blood.V122.21.4559.4559

Published: 2013

Journal Articles

Identification Of Patients At High Risk Of Chronic Graft-Versus-Host Disease: Gvhd Prophylaxis

Gabriel Afram, MD, Jose Antonio Pérez Simón, MD, PhD, Mats Remberger, PhD, Teresa Caballero-Velázquez, MD, PhD, Rodrigo Martino, MD, PhD, Jose Luis Piñana, MD, Olle Ringden, MD, Albert Esquirol, MD, Dolores Caballero, MD, PhD, Irene Garcia, MD, Lucía López-Corral, MD, PhD, Jordi Sierra, Oriana López-Godino, Per T. Ljungman, MD, PhD, Jesus F San Miguel, MD, PhD, Hans Hagglund, MD PhD

Blood (2013) 122 (21): 4611.

https://doi.org/10.1182/blood.V122.21.4611.4611

Published: 2013

Journal Articles

Hypogammaglobulinemia In Children Undergoing SCT: An Immunoglobulin Isotype Class Switch Arrest?

Henric Lindqvist, MD, Mats Remberger, PhD, Berit Sundberg, Mehmet Uzunel, PhD, Jacek Winiarski, MD, PhD, Mikael Sundin, MD, PhD

Blood (2013) 122 (21): 5473.

https://doi.org/10.1182/blood.V122.21.5473.5473

Published: 2013

Journal Articles

The Role Of Vitamin D In Pediatric Hematopoietic Stem Cell Transplantation

Magnus EA Hansson, MD, BA, Anna-Carin Norlin, MD, Brigitta Omazic, MD, PhD, Ann-Charlotte Wikström, MD, PhD, Jacek Winiarski, MD, PhD, Mats Remberger, PhD, Mikael Sundin, MD, PhD

Blood (2013) 122 (21): 5483.

https://doi.org/10.1182/blood.V122.21.5483.5483

Published: 2013

Journal Articles

Prospecitve Quantitative PCR Monitoring of Allogeneic Stem Cell Transplant (SCT) Patients at High Risk for EBV Associated PTLD.

Hamdy Omar, MD, Hans Hägglund, MD, PhD, Åsa Gustafsson-Jernberg, MD, PhD, Katarina Le Blanc, MD, PhD, Jonas Mattsson, MD, PhD, Mats Remberger, PhD, Olle Ringdén, MD, PhD, Elda Sparrelid, MD, PhD, Mikael Sundin, Jacek H. Winiarski, MD, PhD, Zhibing Yun, PhD, Per T. Ljungman, MD, PhD

Blood (2007) 110 (11): 2969.

https://doi.org/10.1182/blood.V110.11.2969.2969

Published: 2007

Journal Articles

Effect of Busulphan Dose Adjustment on Regimen-Related Toxicity.

Zuzana Hassan, MD, PhD, Mats Remberger, PhD, Olle Ringden, Gunnar Oberg, Albert N. Bekassy, MD, PhD, Moustapha Hassan

Blood (2006) 108 (11): 314.

https://doi.org/10.1182/blood.V108.11.314.314

Published: 2006

Journal Articles

Effects of Photopheresis on Mononuclear Cells from Healthy Individuals.

Gunilla Kumlien, MD, Mats Remberger, PhD, Olle Ringdén

Blood (2005) 106 (11): 1903.

https://doi.org/10.1182/blood.V106.11.1903.1903

Published: 2005

Journal Articles

Increased Risk for EBV-Lymphoma after Allogeneic Hsct in Adult Lymphoma Patients?A Retrospective Study of Reduced Compared to Myeloablative Conditioning.

Hans G. Hagglund, MD, PhD, Mats Brune, MD, PhD, Gunnar Oberg, MD, PhD, Hans Hagberg, MD, PhD, Niklas Theorin, MD, Mats Remberger, PhD, Eva Kimby, MD, PhD.

Blood (2004) 104 (11): 5116.

https://doi.org/10.1182/blood.V104.11.5116.5116

Published: 2004

NARROW

Patient Age and Donor HLA Matching Can Stratify Allogeneic Hematopoietic Cell Transplantation (HCT) Patients into Prognostic Groups: A Collaborative Study

Risk Factors for Primary and Secondary Graft Failure in Allogenic Hematopoietic Cell Transplantation: A Single Center Study

Risks and Benefits of Sex-Mismatched Hematopoietic Cell Transplantation Differ By Conditioning Intensity

Graft Failure In Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation

Identification Of Patients At High Risk Of Chronic Graft-Versus-Host Disease: Gvhd Prophylaxis

Hypogammaglobulinemia In Children Undergoing SCT: An Immunoglobulin Isotype Class Switch Arrest?

The Role Of Vitamin D In Pediatric Hematopoietic Stem Cell Transplantation

Prospecitve Quantitative PCR Monitoring of Allogeneic Stem Cell Transplant (SCT) Patients at High Risk for EBV Associated PTLD.

Effect of Busulphan Dose Adjustment on Regimen-Related Toxicity.

Effects of Photopheresis on Mononuclear Cells from Healthy Individuals.

Increased Risk for EBV-Lymphoma after Allogeneic Hsct in Adult Lymphoma Patients?A Retrospective Study of Reduced Compared to Myeloablative Conditioning.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only